White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers
Folia Medica · 2023
DOI: 10.3897/folmed.65.e99159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica, 2023. Verfasst von Vasilii S Chulkov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yaroslav-the-Wise Novgorod State University, Veliky Novgorod, Russia. Hauptthemen laut MEDLINE: White Coat Hypertension, Premature Birth. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertensive disorders of pregnancy are a worldwide health problem for women. They cause complications in up to 10% of pregnancies and are associated with increased maternal and neonatal morbidity and mortality. Traditional blood pressure measurement in clinical practice is the most commonly used procedure for diagnosing and monitoring hypertension treatment, but it is prone to significant inaccuracies caused, on the one hand, by the inherent variability of blood pressure and, on the other, by errors arising from measurement technique and conditions. Some studies have demonstrated a better estimate of the prognosis for the development of cardiovascular diseases using ambulatory blood pressure monitoring. We can detect white-coat hypertension using this method, which helps to avoid overdiagnosis and overtreatment in many cases, and we can also detect masked hypertension, which helps to avoid underdiagnosis and a lack of prescribed treatment if needed. White-coat hypertension is not a benign condition – it has been shown to be associated with higher risks of developing preeclampsia, preterm birth, and small-for-gestational-age babies. In this regard, it is extremely important for clinicians to be aware of the risk factors and outcomes associated with this condition. Pregnant women should be medically monitored both during pregnancy and after delivery to detect target organ damage, cardiovascular risk factors, or a metabolic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yaroslav-the-Wise Novgorod State University, Veliky Novgorod, Russia.
- South-Ural State Medical University, Chelyabinsk, Russia.
ORCID-Profile: Vasilii S Chulkov, Ekaterina Nikolenko, Vladislav Chulkov, Anastasia Podzolko
Zitieren
APA
Chulkov, V. S., Nikolenko, E., Chulkov, V., & Podzolko, A. (2023). White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers. Folia Medica. https://doi.org/10.3897/folmed.65.e99159
Vancouver
Chulkov VS, Nikolenko E, Chulkov V, Podzolko A. White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers. Folia Medica. 2023. doi:10.3897/folmed.65.e99159
BibTeX
@article{Chulkov2023,
author = {Chulkov, Vasilii S and Nikolenko, Ekaterina and Chulkov, Vladislav and Podzolko, Anastasia},
title = {White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers},
journal = {Folia Medica},
year = {2023},
doi = {10.3897/folmed.65.e99159}
}
EUVIMED